Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

SHE:300233 Revenue

Shandong Jincheng Pharmaceutical Group had revenue of 750.42M CNY in the quarter ending March 31, 2026, with 3.95% growth. This brings the company's revenue in the last twelve months to 2.77B, down -12.59% year-over-year. In the year 2025, Shandong Jincheng Pharmaceutical Group had annual revenue of 2.74B, down -18.87%.

• Revenue (ttm): 2.77B
• Revenue Growth: -12.59%
• P/S Ratio: 1.79
• Revenue / Employee: 786.75K
• Employees: 3,515
• Market Cap: 4.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.74B	-636.46M	-18.87%
Dec 31, 2024	3.37B	-164.93M	-4.66%
Dec 31, 2023	3.54B	32.60M	0.93%
Jan 1, 2023	3.51B	367.26M	11.70%
Jan 1, 2022	3.14B	176.52M	5.96%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error